ORLY vs SGMO · P/E 34, rev $9.45B vs rev $57.8M
O’Reilly Automotive Inc (ORLY) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported ORLY revenue for 2026-06-30 was $9.45B. Net income was $1.32B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
ORLY currently screens at market cap $78.32B and trailing P/E 33.7. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the ORLY and SGMO stock pages for the full models.
Not investment advice.